Accession Therapeutics

UK - Oxford

Biotechnology

Focus: Immuno-Oncology Viral Platform

Accession Therapeutics is a life sciences company focused on Immuno-Oncology Viral Platform.

Oncology

Funding Stage

PUBLIC

Open Jobs

Pipeline & Clinical Trials

ATTR-01

Phase 1/2

Clinical Trials (1)

NCT06977737A Study of ATTR-01 in Participants With Select Epithelial Solid Tumours

Phase 1/2

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts

Portfolio: 1 clinical trial

Top TAs: Oncology

Publications: 3 in PubMed

Therapeutic Area Focus

1 pipeline

Marketed

Pipeline